About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Gadoteric acid (IV and intravascular formulations)
- Procedure number
- PSUSA/00001506/202304
- Regulatory outcome
- Variation
Documents
Gadoteric acid (IV and intravascular formulations) : List of nationally authorised medicinal products - PSUSA/00001506/202304
English (EN) (268.37 KB - PDF)
Gadoteric acid (IV and intravascular formulations) : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00001506/202304
English (EN) (412.04 KB - PDF)
български (BG) (191.93 KB - PDF)
español (ES) (176.56 KB - PDF)
čeština (CS) (336.83 KB - PDF)
dansk (DA) (94.65 KB - PDF)
Deutsch (DE) (114.24 KB - PDF)
eesti keel (ET) (95.8 KB - PDF)
ελληνικά (EL) (155.71 KB - PDF)
français (FR) (269.22 KB - PDF)
hrvatski (HR) (327.43 KB - PDF)
íslenska (IS) (179.67 KB - PDF)
italiano (IT) (262.32 KB - PDF)
latviešu valoda (LV) (343.97 KB - PDF)
lietuvių kalba (LT) (340.52 KB - PDF)
magyar (HU) (270.36 KB - PDF)
Malti (MT) (147.52 KB - PDF)
Nederlands (NL) (179.37 KB - PDF)
norsk (NO) (102.3 KB - PDF)
polski (PL) (332.41 KB - PDF)
português (PT) (178.17 KB - PDF)
română (RO) (265.04 KB - PDF)
slovenčina (SK) (145.57 KB - PDF)
slovenščina (SL) (323.44 KB - PDF)
Suomi (FI) (173.14 KB - PDF)
svenska (SV) (176.86 KB - PDF)